Navigation Links
NCPA Statement on Florida Study About Prescription Drug Prices in Underserved Areas
Date:11/5/2008

ALEXANDRIA, Va., Nov. 5 /PRNewswire-USNewswire/ -- Health Service Online has published a study called "Variation in Drug Prices at Pharmacies: Are Drug Prices Higher in Poor Areas," by Walid F. Gellad. In response, Bruce T. Roberts, RPh, National Community Pharmacists Association (NCPA) executive vice president and CEO, issued the following statement.

"The study by Dr. Walid Gellad is helpful in raising awareness about the variation in prescription drug prices between wealthier and poorer neighborhoods in Florida, but unfortunately misses the mark in many ways. For example, more than 90 percent of prescription drug prices are set by large pharmacy benefit managers (PBMs) with no ability for community pharmacies to negotiate, so these small businesses literally can't influence what their patients pay. In addition, underserved and rural communities often have a higher percentage of Medicaid and Medicare patients, making the number of cash prescriptions minimal. On a related note, using 'U&C' (usual and customary) as the data point for measuring cash pricing in the study is antiquated. In reality, U&C was an appropriate indicator decades ago when the majority of prescriptions were paid by cash; however that's now the exception rather than the rule."

"However, the study highlights one very important concern--the lack of access to a community pharmacy in rural and underserved areas. Large drugstore chains sometimes avoid these areas due to profitability concerns, often leaving pharmacy small business owners as the last hope for fulfilling the medications needs in these areas. Unfortunately, take-it-or-leave-it PBM contracts in Florida have resulted in no retail pharmacy presence in 74 ZIP codes where the median income is under $30,000, representing slightly over 185,000 people. This dynamic needs to be remedied."

"The best solution for helping those living in underserved neighborhoods is to allow community pharmacy owners to have good faith business negotiations with Wall Street's giant PBMs as is the case with the companion bills pending in the U.S. Congress - H.R. 971 and S. 2161. Fair contracts would allow more community pharmacies to operate and ensure patients have the medication access they need to stay healthy."

For a more comprehensive analysis of the study by NCPA, please go to the following link: http://www.ncpanet.org/pdf/drugpricesstudy.pdf

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... A new ... the world. The Duke Clinical Research Institute (DCRI) and analytics leader SAS will provide ... patient data collected by the Duke University Health System. , The DCRI and ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... 2016. SS&A teamed up with one of the top website design companies to ... contains informative legal articles related to the law firm's main practice areas. These ...
(Date:5/4/2016)... NC (PRWEB) , ... May 04, 2016 , ... Francesca ... N.C., changed her life forever with a same-day LASIK procedure at Christenbury ... poor eyesight. Dr. Jonathan Christenbury performed her surgery the same day as her in-office ...
(Date:5/4/2016)... ... 04, 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which is ... hosting a free seminar on stem cell injections. The seminar is scheduled for Wednesday, ... 4601 Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... powerful cellular therapy software application that helps blood and marrow transplant (BMT) programs ... Transtem’s initial launch, Mediware has continued to enhance core application features. These enhancements ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Actinic Keratosis Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Actinic Keratosis market valuations and forecast, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: